ESTRO meets Asia 2024 - Abstract Book

S131

Interdisciplinary – Global health

ESTRO meets Asia 2024

[39] Romero Y, Trapani D, Johnson S, et al. National cancer control plans: a global analysis. Lancet Oncol. 2018;19(10):e546-e555.

[40] Roadmap towards a National Cancer Control Programme. Vienna, Austria: International Atomic Energy Agency; 2019. https://www.iaea.org/sites/default/files/19/10/milestones-document-2019.pdf (accessed February 6, 2024).

[41] Chen S, Cao Z, Prettner K, et al. Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050. JAMA Oncol. 2023;9(4):465-472.

[42] Nadella P, Iyer HS, Manirakiza A, et al. Geographic Accessibility of Radiation Therapy Facilities in Sub-Saharan Africa. Int J Radiat Oncol Biol Phys. 2023;115(3):557-563.

[43] Taylor PA, Miles E, Hoffmann L, Kelly SM, Kry SF, Sloth Møller D, Palmans H, Akbarov K, Aznar MC, Clementel E, Corning C, Effeney R, Healy B, Moore A, Nakamura M, Patel S, Shaw M, Stock M, Lehmann J, Clark CH. Prioritizing clinical trial quality assurance for photons and protons: A failure modes and effects analysis (FMEA) comparison. Radiother Oncol. 2023;182:109494.

[44] Samiei M. Challenges of making radiotherapy accessible in developing countries. Cancer Control. 2013:85– 94.

[45] Deressa BT, Tigeneh W, Bogale N, Buwenge M, Morganti AG, Farina E. Short-Course 2-Dimensional Radiation Therapy in the Palliative Treatment of Esophageal Cancer in a Developing Country: A Phase II Study (Sharon Project). Int J Radiat Oncol Biol Phys. 2020;106(1):67-72.

[46] Page BR, Hudson AD, Brown DW, et al. Cobalt, linac, orother: what is the best solution for radiation therapy in developing countries? Int J Radiat Oncol Biol Phys. 2014;89:476–480.

[47] Kraus RD, Weil CR, Abdel-Wahab M. Benefits of adopting hypofractionated radiotherapy as a standard of care in low-and middle-income countries. JCO Glob Oncol 2022; 8: e2200215

[48] Datta NR, Heuser M, Bodis S. A Roadmap and Cost Implications of Establishing Comprehensive Cancer Care Using a Teleradiotherapy Network in a Group of Sub-Saharan African Countries With No Access to Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016;95(5):1334-1343.

[49] Abdel-Wahab M, Rosenblatt E, Prajogi B, Zubizarretta E, Mikhail M. Opportunities in Telemedicine, Lessons Learned After COVID-19 and the Way Into the Future. Int J Radiat Oncol Biol Phys. 2020;108(2):438-443.

[50] Veljkovikj I, Ilbawi AM, Roitberg F, Luciani S, Barango P, Corbex M, Dorji G, Gunawardena N, Johnson S, Juric A, Siewert K, Saporiti G, Nobile M, Sauvaget C, Vidanapathirana J, Wright B, Lishimpi K, Kaidarova D, Pomata A, Malick A, Dangou JM, Abdel-Wahab M, Weiderpass E, Mikkelsen B, Stevens LM. Evolution of the joint International Atomic Energy Agency (IAEA), International Agency for Research on Cancer (IARC), and WHO cancer control assessments (imPACT Reviews). Lancet Oncol. 2022;23(10):e459-e468. [51] Jaffray DA, Knaul FM, Atun R, Adams C, Barton MB, Baumann M, Lievens Y, Lui TY, Rodin DL, Rosenblatt E, Torode J, Van Dyk J, Vikram B, Gospodarowicz M. Global Task Force on Radiotherapy for Cancer Control. Lancet Oncol. 2015;16(10):1144-6

[52] Coleman CN, Wendling EN, Pistenmaa DA. A Broad Impact for Global Oncology. JAMA Oncol. 2019;5(10):1397 1398.

[53] Price P, Barney SE. Initiation of the Global Coalition for Radiotherapy during the COVID-19 pandemic. Lancet Oncol. 2020;21(6):752-753.